LOZZA, ALESSANDRO
 Distribuzione geografica
Continente #
NA - Nord America 323
EU - Europa 226
AS - Asia 97
Continente sconosciuto - Info sul continente non disponibili 1
Totale 647
Nazione #
US - Stati Uniti d'America 322
IE - Irlanda 107
CN - Cina 54
DE - Germania 30
FI - Finlandia 29
SG - Singapore 24
IT - Italia 20
RU - Federazione Russa 16
BE - Belgio 14
IN - India 14
CZ - Repubblica Ceca 3
FR - Francia 2
JP - Giappone 2
AT - Austria 1
CA - Canada 1
EU - Europa 1
GB - Regno Unito 1
LT - Lituania 1
MD - Moldavia 1
MY - Malesia 1
NP - Nepal 1
RO - Romania 1
TR - Turchia 1
Totale 647
Città #
Dublin 103
Chandler 83
Boardman 26
Helsinki 26
Ashburn 20
Singapore 20
Ann Arbor 19
Brussels 14
Pune 14
Lawrence 12
Los Angeles 12
Princeton 12
Medford 11
Munich 11
Nanjing 10
Shanghai 10
Jacksonville 8
Shenyang 7
Beijing 6
Fairfield 6
Wilmington 6
St Petersburg 5
Cambridge 4
Chicago 4
Hanover 4
Nanchang 4
Naples 4
Norwalk 4
Pavia 4
Woodbridge 4
Brno 3
Changsha 3
Dearborn 3
Hangzhou 3
Menlo Park 3
Moscow 3
Piscataway 3
Chignolo d'Isola 2
Falkenstein 2
Florence 2
Hebei 2
New York 2
Tokyo 2
Voronezh 2
Andover 1
Balakovo 1
Berlin 1
Cedar Knolls 1
Chisinau 1
Dallas 1
Fuzhou 1
Gatchina 1
Guangzhou 1
Hefei 1
Hunedoara 1
Jiaxing 1
Kathmandu 1
Kuala Lumpur 1
Leawood 1
Lincoln 1
London 1
Macerata 1
Milan 1
Ningbo 1
Nizhniy Novgorod 1
Novara 1
Orange 1
Perm 1
Perugia 1
Rome 1
Secaucus 1
Tianjin 1
Toronto 1
Yekaterinburg 1
Totale 538
Nome #
Combined central and peripheral demyelination: Clinical features, diagnostic findings, and treatment 76
Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study 69
Repurposing diflunisal for familial amyloid polyneuropathy: A randomized clinical trial 63
Rehabilitation and functional recovery after masseteric-facial nerve anastomosis 54
Efficacy of rituximab as third-line therapy in combined central and peripheral demyelination 45
Autoantibodies to nodal isoforms of neurofascin in chronic inflammatory demyelinating polyneuropathy 45
Copper deficiency in Wilson's disease: Peripheral neuropathy and myelodysplastic syndrome complicating zinc treatment 44
Guillain-Barré syndrome associated with the D222E variant of the 2009 pandemic influenza A (H1N1) virus: Case report and review of the literature 42
Erratum to: Monitoring effectiveness and safety of Tafamidis in transthyretin amyloidosis in Italy: a longitudinal multicenter study in a non-endemic area (Journal of Neurology, DOI: 10.1007/s00415-016-8064-9) 41
Monitoring late complications of zinc treatment in Wilson's disease. Reply to the letter: Copper deficiency in Wilson's disease: An avoidable complication of treatment: Monitoring Late Complications of Zinc Treatment in Wilson's Disease 40
Diagnostic challenges in hereditary transthyretin amyloidosis with polyneuropathy: Avoiding misdiagnosis of a treatable hereditary neuropathy 39
Adult-onset type II glycogenosis (GSDII): Clinical spectrum and enzyme replacement therapy (ERT) 38
Laryngeal and phrenic nerve involvement in a patient with hereditary neuropathy with liability to pressure palsies (HNPP) 35
Muscle quantitative MRI as a novel biomarker in hereditary transthyretin amyloidosis with polyneuropathy: a cross-sectional study 32
Long-term treatment of hereditary transthyretin amyloidosis with patisiran: multicentre, real-world experience in Italy 2
Totale 665
Categoria #
all - tutte 3.735
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.735


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202011 0 0 0 0 0 1 2 1 0 2 5 0
2020/202129 0 0 0 1 7 0 0 12 2 2 0 5
2021/202278 1 0 3 1 0 13 1 3 5 2 13 36
2022/2023269 18 24 8 22 19 27 5 9 126 1 8 2
2023/2024139 18 15 1 9 9 36 4 6 1 16 9 15
2024/202581 7 16 4 11 20 23 0 0 0 0 0 0
Totale 665